Japanese contract research company in Chuo-ku, Kumamoto, established in August 2020 and led by Hiroko Tabuchi, which supports quantitative decision making in drug development. Carries out modelling and simulation and pharmacometric analysis for pharmaceutical clients from early clinical projects through to large phase three analyses supporting new drug applications, provides consulting on modelling and simulation, develops information technology products and an eLearning system that make these methods more accessible, and works as a technical and information services business.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét